Mira Pharmaceuticals (MIRA) Current Leases (2022 - 2024)

Mira Pharmaceuticals (MIRA) posted Current Leases of $1273.0 for Q1 2024, down 74.85% sequentially from $5061.0 in Q4 2023.

Mira Pharmaceuticals (MIRA) Current Leases (2022 - 2024) Analysis & Trends

Mira Pharmaceuticals (MIRA) has 3 years of Current Leases data on file, last reported at $1273.0 in Q1 2024.

  • Quarterly Current Leases changed N/A year-over-year to $1273.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $1273.0 (changed N/A YoY) and the FY2023 annual result came in at $5061.0, down 93.26% from the prior year.
  • Current Leases declined to $1273.0 in Q1 2024 per MIRA's latest filing, from $5061.0 in the prior quarter.
  • The five-year high for Current Leases was $75362.0 in Q2 2023, with the low at $1273.0 in Q1 2024.
  • Average Current Leases over 3 years is $46233.4, with a median of $74328.0 recorded in 2023.
  • The widest YoY moves for Current Leases: up 93.26% in 2023, down 93.26% in 2023.
  • Mira Pharmaceuticals' Current Leases stood at $75143.0 in 2022, then slumped by 93.26% to $5061.0 in 2023, then plunged by 74.85% to $1273.0 in 2024.
  • Business Quant data shows MIRA's Current Leases at $1273.0 in Q1 2024, $5061.0 in Q4 2023, and $74328.0 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - 271.00 Mn
10 Mira Pharmaceuticals 22.51 Mn 11.48 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2024 1,273.00
Dec 31, 2023 5,061.00
Sep 30, 2023 74,328.00
Jun 30, 2023 75,362.00
Dec 31, 2022 75,143.00